Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Journal for Immunotherapy of Cancer
|
October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells
Seth M Pollack, Robin L Jones, Erik A Farrar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Multiplexed Evaluation of Microdosed Antineoplastic Agents <i>In Situ</i> in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma
Kenneth R Gundle, Gary B Deutsch, Howard J Goodman, et al.
Cancer Immunology Research
|
February 20, 2026
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15
Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, et al.
Oncoimmunology
|
December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Journal for Immunotherapy of Cancer
|
September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
Brett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Cancers
|
September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy
Karan Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.
Molecular Cancer Therapeutics
|
April 11, 2022
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
Shihong Zhang, R Graeme Black, Karan Kohli, et al.
Frontiers in Oncology
|
June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series
Jessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Journal for Immunotherapy of Cancer
|
October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells
Seth M Pollack, Robin L Jones, Erik A Farrar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Multiplexed Evaluation of Microdosed Antineoplastic Agents <i>In Situ</i> in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma
Kenneth R Gundle, Gary B Deutsch, Howard J Goodman, et al.
Cancer Immunology Research
|
February 20, 2026
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15
Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, et al.
Oncoimmunology
|
December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Journal for Immunotherapy of Cancer
|
September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
Brett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Cancers
|
September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy
Karan Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.
Molecular Cancer Therapeutics
|
April 11, 2022
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
Shihong Zhang, R Graeme Black, Karan Kohli, et al.
Frontiers in Oncology
|
June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series
Jessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
Page
of 11